Literature DB >> 29209835

Patient-clinician communication among patients with stage I lung cancer.

Shannon M Nugent1,2, Sara E Golden3, Charles R Thomas4, Mark E Deffebach5,6, Mithran S Sukumar7, Paul H Schipper7, Brandon H Tieu7, Drew Moghanaki8, Juan Wisnivesky9, Christopher Slatore3,4,5,6.   

Abstract

PURPOSE: Limited data exist about patient-centered communication (PCC) and patient-centered outcomes among patients who undergo surgery or stereotactic body radiation therapy (SBRT) for stage I non-small cell lung cancer (NSCLC). We aimed to examine the relationship between PCC and decision-making processes among NSCLC patients, using baseline data from a prospective, multicenter study.
METHODS: Patients with stage 1 NSCLC completed a survey prior to treatment initiation. The survey assessed sociodemographic characteristics, treatment decision variables, and patient psychosocial outcomes: health-related quality of life (HRQOL), treatment self-efficacy, decisional conflict, and PCC.
RESULTS: Fifty-two percent (n = 85) of 165 individuals planned to receive SBRT. There were no baseline differences detected on patient psychosocial outcomes between those who planned to receive SBRT or surgery. All participants reported high HRQOL (M = 72.5, SD = 21.3) out of 100, where higher scores indicate better functioning; high self-efficacy (M = 1.5, SD = 0.5) out of 6, where lower numbers indicate higher self-efficacy; minimal decisional conflict (M = 15.2, SD = 12.7) out of 100, where higher scores indicate higher decisional conflict; and high levels of patient-centered communication (M = 2.4, SD = 0.8) out of 7 where higher scores indicate worse communication. Linear regression analyses adjusting for sociodemographic and clinical variables showed that higher quality PCC was associated with higher self-efficacy (β = 0.17, p = 0.03) and lower decisional conflict (β = 0.42, p < 0.001).
CONCLUSIONS: Higher quality PCC was associated with higher self-efficacy and lower decisional conflict. Self-efficacy and decisional conflict may influence subsequent health outcomes. Therefore, our findings may inform future research and clinical programs that focus on communication strategies to improve these outcomes.

Entities:  

Keywords:  Lung cancer; Patient-clinician communication; Psychosocial outcomes; Stereotactic radiation therapy

Mesh:

Year:  2017        PMID: 29209835     DOI: 10.1007/s00520-017-3992-1

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  32 in total

1.  Stereotactic body radiation therapy for inoperable early stage lung cancer.

Authors:  Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

2.  The process of recovery from breast cancer for younger and older patients. Changes during the first year.

Authors:  A D Vinokur; B A Threatt; D Vinokur-Kaplan; W A Satariano
Journal:  Cancer       Date:  1990-03-01       Impact factor: 6.860

Review 3.  Stereotactic body radiation therapy: scope of the literature.

Authors:  Kelley Tipton; Jason H Launders; Rohit Inamdar; Curtis Miyamoto; Karen Schoelles
Journal:  Ann Intern Med       Date:  2011-05-02       Impact factor: 25.391

Review 4.  Patient-reported outcome use in oncology: a systematic review of the impact on patient-clinician communication.

Authors:  L Y Yang; D S Manhas; A F Howard; R A Olson
Journal:  Support Care Cancer       Date:  2017-08-28       Impact factor: 3.603

5.  What the heck is a "nodule"? A qualitative study of veterans with pulmonary nodules.

Authors:  Christopher G Slatore; Nancy Press; David H Au; J Randall Curtis; Renda Soylemez Wiener; Linda Ganzini
Journal:  Ann Am Thorac Soc       Date:  2013-08

6.  Development and validation of the Communication and Attitudinal Self-Efficacy scale for cancer (CASE-cancer).

Authors:  Michael S Wolf; Chih-Hung Chang; Terry Davis; Gregory Makoul
Journal:  Patient Educ Couns       Date:  2005-06

7.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

8.  Clinical practice patterns of lung stereotactic body radiation therapy in the United States: a secondary analysis.

Authors:  Hubert Pan; Brent S Rose; Daniel R Simpson; Loren K Mell; Arno J Mundt; Joshua D Lawson
Journal:  Am J Clin Oncol       Date:  2013-06       Impact factor: 2.339

9.  Decisional conflict in economically disadvantaged men with newly diagnosed prostate cancer: baseline results from a shared decision-making trial.

Authors:  Alan L Kaplan; Catherine M Crespi; Josemanuel D Saucedo; Sarah E Connor; Mark S Litwin; Christopher S Saigal
Journal:  Cancer       Date:  2014-05-09       Impact factor: 6.860

10.  Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial.

Authors:  Alexander V Louie; Erik van Werkhoven; Hanbo Chen; Egbert F Smit; Marinus A Paul; Joachim Widder; Harry J M Groen; Ben E E M van den Borne; Katrien De Jaeger; Ben J Slotman; Suresh Senan
Journal:  Radiother Oncol       Date:  2015-10       Impact factor: 6.280

View more
  4 in total

1.  Understanding patients' values and preferences regarding early stage lung cancer treatment decision making.

Authors:  Donald R Sullivan; Karen B Eden; Nathan F Dieckmann; Sara E Golden; Kelly C Vranas; Shannon M Nugent; Christopher G Slatore
Journal:  Lung Cancer       Date:  2019-03-09       Impact factor: 5.705

2.  Patient-clinician communication and patient-centered outcomes among patients with suspected stage I non-small cell lung cancer: a prospective cohort study.

Authors:  Shannon M Nugent; Sara E Golden; Donald R Sullivan; Charles R Thomas; Juan Wisnivesky; Somnath Saha; Christopher G Slatore
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

3.  Early-Stage Lung Cancer Patients' Perceptions of Presurgical Discussions.

Authors:  Rebecca M Schwartz; Rowena Yip; Nan You; Christina Gillezeau; Kimberly Song; David F Yankelevitz; Emanuela Taioli; Claudia I Henschke; Raja M Flores
Journal:  MDM Policy Pract       Date:  2022-03-21

4.  A Secure Occupational Therapy Framework for Monitoring Cancer Patients' Quality of Life.

Authors:  Md Abdur Rahman; Md Mamunur Rashid; Julien Le Kernec; Bruno Philippe; Stuart J Barnes; Francesco Fioranelli; Shufan Yang; Olivier Romain; Qammer H Abbasi; George Loukas; Muhammad Imran
Journal:  Sensors (Basel)       Date:  2019-11-29       Impact factor: 3.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.